ClinicalTrials.Veeva

Menu
E

Evolution Research Group | Woodland Research Northwest

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SEP-363856
Rapastinel
Edaravone
Cariprazine
Brexpiprazole
MK-8189
Risperidone
JNJ-42847922
Glucose
Rimegepant

Parent organization

This site is a part of Evolution Research Group

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 62 total trials

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmuco...

Enrolling
Treatment Resistant Depression
Drug: VLS-01-BU Placebo
Drug: VLS-01-203 BU

This is a Phase 2 study randomized, quadruple masked, multi-center study , with a Open Label Extension, designed to investigate the efficacy and safe...

Active, not recruiting
Treatment Resistant Depression
Drug: BPL-003

The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)

Enrolling
Generalized Anxiety Disorder
Drug: Placebo
Drug: ENX-102

Trial sponsors

Otsuka logo
AbbVie logo
Allergan logo
Jazz Pharmaceuticals logo
Merck Sharp & Dohme (MSD) logo
Mitsubishi Tanabe Pharma logo
Janssen (J&J Innovative Medicine) logo
R
Pfizer logo
R

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems